Terminated PHASE3 INTERVENTIONAL 2-arm NCT02574156

Control of Hyperglycemia After Cardiac Surgery: CHyCS Trial (CHyCS)

Sponsor: InCor Heart Institute

Interventions Insulin

Updated 8 times since 2017 Last updated: Oct 31, 2022 Started: Jan 1, 2017 Primary completion: Aug 1, 2018 Completion: Apr 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Finished

Other terminated trials from InCor Heart Institute

Acquired Tracheo-esophageal Fistula · Phase PHASE4 · Dec 2012

See all terminations from InCor Heart Institute

Other Hyperglycemia trials with similar outcome

Browse all Hyperglycemia trials

This PHASE3 trial investigates Hyperglycemia and is currently terminated or withdrawn. InCor Heart Institute leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Dec 2022 — Jul 2024 [monthly]

Terminated PHASE3

Status: Unknown Status → Terminated
Jan 2021 — Dec 2022 [monthly]

Unknown Status PHASE3
Jun 2019 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Jun 2019 [monthly]

Recruiting PHASE3
Jul 2017 — Jun 2018 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Jan 2017 — Jul 2017 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

InCor Heart Institute
University of Sao Paulo

Data source: University of Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil